Thalidomide Maintenance in Multiple Myeloma: Certainties and Controversies Reply

被引：1
|
作者：
Spencer, Andrew [1 ]
Prince, H. Miles [2 ]
Roberts, Andrew W. [3 ]
机构：
[1] Alfred Hosp, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 32期
关键词：
CONSOLIDATION THERAPY; SURVIVAL;
D O I：
10.1200/JCO.2009.24.0853
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E188 / E188
页数：1
相关论文
共 50 条
  • [41] Risk adapted post-transplant maintenance in multiple myeloma
    Vaxman, Iuliana
    Gertz, Morie
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (02) : 107 - 118
  • [42] Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment
    Morabito, Fortunato
    Gentile, Massimo
    Mazzone, Carla
    Rossi, Davide
    Di Raimondo, Francesco
    Bringhen, Sara
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Petrucci, Maria Teresa
    Benevolo, Giulia
    Vincelli, Iolanda
    Guglielmelli, Tommasina
    Grasso, Mariella
    Marasca, Roberto
    Baldini, Luca
    Montefusco, Vittorio
    Musto, Pellegrino
    Cascavilla, Nicola
    Majolino, Ignazio
    Musolino, Caterina
    Cavo, Michele
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2011, 118 (22) : 5759 - 5766
  • [43] Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
    Zhu, Yuan Xiao
    Kortuem, K. Martin
    Stewart, A. Keith
    LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 683 - 687
  • [44] Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation
    Morgan, Gareth J.
    Davies, Faith E.
    Gregory, Walter M.
    Russell, Nigel H.
    Bell, Sue E.
    Szubert, Alexander J.
    Coy, Nuria Navarro
    Cook, Gordon
    Feyler, Sylvia
    Byrne, Jenny L.
    Roddie, Huw
    Rudin, Claudius
    Drayson, Mark T.
    Owen, Roger G.
    Ross, Fiona M.
    Jackson, Graham H.
    Child, J. Anthony
    BLOOD, 2011, 118 (05) : 1231 - 1238
  • [45] Phase II Study of Thalidomide Plus Dexamethasone Induction Followed by Tandem Melphalan-Based Autotransplantation and Thalidomide-Plus-Prednisone Maintenance for Untreated Multiple Myeloma: A Southwest Oncology Group Trial (S0204)
    Hussein, Mohamad A.
    Bolejack, Vanessa
    Zonder, Jeffrey A.
    Durie, Brian G. M.
    Jakubowiak, Andrzej J.
    Crowley, John J.
    Barlogie, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3510 - 3517
  • [46] Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma
    Alonso, Rafael
    Cedena, Maria-Teresa
    Wong, Sandy
    Shah, Nina
    Rios-Tamayo, Rafael
    Moraleda, Jose M.
    Lopez-Jimenez, Javier
    Garcia, Cristina
    Bahri, Natasha
    Valeri, Antonio
    Sanchez, Ricardo
    Collado-Yurrita, Luis
    Martin, Thomas
    Wolf, Jeffrey
    Lahuerta, Juan-Jose
    Martinez-Lopez, Joaquin
    BLOOD ADVANCES, 2020, 4 (10) : 2163 - 2171
  • [47] Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
    Attal, Michel
    Lauwers-Cances, Valerie
    Marit, Gerald
    Caillot, Denis
    Moreau, Philippe
    Facon, Thierry
    Stoppa, Anne Marie
    Hulin, Cyrille
    Benboubker, Lofti
    Garderet, Laurent
    Decaux, Olivier
    Leyvraz, Serge
    Vekemans, Marie-Christiane
    Voillat, Laurent
    Michallet, Mauricette
    Pegourie, Brigitte
    Dumontet, Charles
    Roussel, Murielle
    Leleu, Xavier
    Mathiot, Claire
    Payen, Catherine
    Avet-Loiseau, Herve
    Harousseau, Jean-Luc
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) : 1782 - 1791
  • [48] New Developments in Post-transplant Maintenance Treatment of Multiple Myeloma
    Liu, Hong
    McCarthy, Philip
    SEMINARS IN ONCOLOGY, 2013, 40 (05) : 602 - 609
  • [49] A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma
    Fuchida, Shin-ichi
    Sunami, Kazutaka
    Matsumoto, Morio
    Okumura, Hirokazu
    Murayama, Tohru
    Miyamoto, Toshihiro
    Otsuka, Eichi
    Fujishima, Naohito
    Izumi, Tohru
    Tamaki, Shigehisa
    Hiramatsu, Yasushi
    Kuroda, Yoshiaki
    Shimazaki, Chihiro
    Akashi, Koichi
    Harada, Mine
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 107 - 114
  • [50] Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma
    Sonneveld, Pieter
    Asselbergs, Emilie
    Zweegman, Sonja
    van der Holt, Bronno
    Kersten, Marie Jose
    Vellenga, Edo
    van Marwijk-Kooy, Marinus
    Broyl, Annemiek
    de Weerdt, Okke
    Lonergan, Sarah
    Palumbo, Antonio
    Lokhorstl, Henk
    BLOOD, 2015, 125 (03) : 449 - 456
12345